MARIZYME INC Contracts & Agreements

Promissory Note, dated July 12, 2024, in favor of Lender (Filed With SEC on July 18, 2024)

Description of Securities of Marizyme, Inc (Filed With SEC on May 13, 2024)

Letter Agreement between Marizyme, Inc. and Univest Securities, LLC, as Unitholder Representative for the Investors, dated December 21, 2023 (Filed With SEC on December 28, 2023)

Form of 15% Original Issue Discount Unsecured Subordinated Convertible Promissory Note issued by Marizyme, Inc. for cash, dated November 20, 2023 (Filed With SEC on November 21, 2023)

Form of 15% Original Issue Discount Unsecured Subordinated Convertible Promissory Note issued by Marizyme, Inc. for cancellation of certain indebtedness, dated November 20, 2023 (Filed With SEC on November 21, 2023)

Form of Class E Common Stock Purchase Warrant issued by Marizyme, Inc. for cash, dated November 20, 2023 (Filed With SEC on November 21, 2023)

Form of Class E Common Stock Purchase Warrant issued by Marizyme, Inc. for cancellation of certain indebtedness, dated November 20, 2023 (Filed With SEC on November 21, 2023)

Form of Class F Common Stock Purchase Warrant issued by Marizyme, Inc. for cash, dated November 20, 2023 (Filed With SEC on November 21, 2023)

Form of Class F Common Stock Purchase Warrant issued by Marizyme, Inc. for cancellation of certain indebtedness, dated November 20, 2023 (Filed With SEC on November 21, 2023)

Unit Purchase Agreement between Marizyme, Inc. and the investors identified on Appendix A thereto, dated as of November 20, 2023 (Filed With SEC on November 21, 2023)

Registration Rights Agreement between Marizyme, Inc. and the purchasers signatory thereto, dated as of November 20, 2023 (Filed With SEC on November 21, 2023)

Form of Cancellation and Exchange Agreement between Marizyme, Inc. and the creditor party thereto, dated as of November 20, 2023 (Filed With SEC on November 21, 2023)

Form of Waiver and Consent, dated as of November 20, 2023, between Marizyme, Inc. and each investor identified on Appendix A to the Unit Purchase Agreement between Marizyme, Inc.... (Filed With SEC on November 21, 2023)

Form of Waiver and Consent, dated as of November 20, 2023, between Marizyme, Inc. and Univest Securities, LLC or its designee (Filed With SEC on November 21, 2023)

Marizyme Employment Terms and Conditions Agreement, dated January 14, 2021, between Marizyme, Inc. and Dr. Steven Brooks (Filed With SEC on October 24, 2023)

Waiver and Consent between Marizyme, Inc. and Bologna Family Restaurant Spa, dated as of June 5, 2023 (Filed With SEC on October 12, 2023)

Waiver and Consent between Marizyme, Inc. and Allesia Solimeo, dated as of July 20, 2023 (Filed With SEC on October 12, 2023)

Waiver and Consent between Marizyme, Inc. and Alessandro Solimeo, dated as of July 21, 2023 (Filed With SEC on October 12, 2023)

Letter Agreement between Marizyme, Inc. and Outside The Box Capital Inc., dated as of August 17, 2023 (Filed With SEC on October 12, 2023)

Waiver and Consent between Marizyme, Inc. and Pioneer Capital Anstalt, dated as of September 7, 2023 (Filed With SEC on October 12, 2023)

Placement Agent Warrant, dated October 3, 2023, issued to Univest Securities, LLC (Filed With SEC on October 4, 2023)

Placement Agent Warrant, dated October 3, 2023, issued to Bradley Richmond (Filed With SEC on October 4, 2023)

Letter Agreement between Marizyme, Inc. and Univest Securities, LLC, as Unitholder Representative for the Investors, dated October 3, 2023 (Filed With SEC on October 4, 2023)

Form of 15% Original Issue Discount Unsecured Subordinated Convertible Promissory Note issued by Marizyme, Inc., dated August 30, 2023 (Filed With SEC on September 5, 2023)

15% Original Issue Discount Unsecured Subordinated Convertible Promissory Note issued by Marizyme, Inc. to Frank Maresca, dated August 30, 2023 (Filed With SEC on September 5, 2023)

Form of Class E Common Stock Purchase Warrant issued by Marizyme, Inc., dated August 30, 2023 (Filed With SEC on September 5, 2023)

Class E Common Stock Purchase Warrant issued by Marizyme, Inc. to Frank Maresca, dated August 30, 2023 (Filed With SEC on September 5, 2023)

Form of Class F Common Stock Purchase Warrant issued by Marizyme, Inc., dated August 30, 2023 (Filed With SEC on September 5, 2023)

Class F Common Stock Purchase Warrant issued by Marizyme, Inc. to Frank Maresca, dated August 30, 2023 (Filed With SEC on September 5, 2023)

Form of Placement Agent Warrant with respect to 15% Original Issue Discount Unsecured Subordinated Convertible Promissory Notes (Filed With SEC on September 5, 2023)

Form of Placement Agent Warrant with respect to Class E Common Stock Purchase Warrants (Filed With SEC on September 5, 2023)

Form of Placement Agent Warrant with respect to Class F Common Stock Purchase Warrants (Filed With SEC on September 5, 2023)

Unit Purchase Agreement between Marizyme, Inc. and the investors identified on Appendix A thereto, dated as of August 30, 2023 (Filed With SEC on September 5, 2023)

Registration Rights Agreement between Marizyme, Inc. and the purchasers signatory thereto, dated as of August 30, 2023 (Filed With SEC on September 5, 2023)

Cancellation and Exchange Agreement between Marizyme, Inc. and Frank Maresca, dated as of August 30, 2023 (Filed With SEC on September 5, 2023)

Waiver and Consent between Marizyme, Inc. and Waichun Logistics Technology Ltd, dated as of April 12, 2023 (Filed With SEC on August 18, 2023)

Class C Common Stock Purchase Warrant, dated July 25, 2023, issued to Univest Securities, LLC (Filed With SEC on July 31, 2023)

Class C Common Stock Purchase Warrant, dated July 25, 2023, issued to Bradley Richmond (Filed With SEC on July 31, 2023)

10% Secured Convertible Promissory Note, dated July 25, 2023, issued to Univest Securities, LLC (Filed With SEC on July 31, 2023)

10% Secured Convertible Promissory Note, dated July 25, 2023, issued to Bradley Richmond (Filed With SEC on July 31, 2023)

Placement Agent Warrant, dated July 25, 2023, issued to Univest Securities, LLC (Filed With SEC on July 31, 2023)

Placement Agent Warrant, dated July 25, 2023, issued to Bradley Richmond (Filed With SEC on July 31, 2023)

Form of Waiver and Consent with respect to certain registration and exercise rights dated on or around June 9, 2023 (Filed With SEC on July 18, 2023)

15% Original Issue Discount Unsecured Subordinated Convertible Promissory Note issued by Marizyme, Inc., dated July 10, 2023 (Filed With SEC on July 12, 2023)

Class E Common Stock Purchase Warrant issued by Marizyme, Inc., dated July 10, 2023 (Filed With SEC on July 12, 2023)

Class F Common Stock Purchase Warrant issued by Marizyme, Inc., dated July 10, 2023 (Filed With SEC on July 12, 2023)

Unit Purchase Agreement between Marizyme, Inc. and the investor identified on Appendix A thereto, dated July 10, 2023 (Filed With SEC on July 12, 2023)

Registration Rights Agreement between Marizyme, Inc. and the purchaser signatory thereto, dated July 10, 2023 (Filed With SEC on July 12, 2023)

Amendment to Registration Rights Agreement, dated July 6, 2023, between Marizyme, Inc. and each of the several investors signatory thereto (Filed With SEC on July 12, 2023)

15% Original Issue Discount Unsecured Subordinated Convertible Promissory Note issued by Marizyme, Inc. to Hexin Global Ltd., dated May 30, 2023 (Filed With SEC on June 5, 2023)

Class E Common Stock Purchase Warrant issued by Marizyme, Inc. to Hexin Global Ltd., dated May 30, 2022 (Filed With SEC on June 5, 2023)

Class F Common Stock Purchase Warrant issued by Marizyme, Inc. to Hexin Global Ltd., dated May 30, 2022 (Filed With SEC on June 5, 2023)

15% Original Issue Discount Unsecured Subordinated Convertible Promissory Note issued by Marizyme, Inc. to Walleye Opportunities Master Fund Ltd, dated May 30, 2023 (Filed With SEC on June 5, 2023)

Class E Common Stock Purchase Warrant issued by Marizyme, Inc. to Walleye Opportunities Master Fund Ltd, dated May 30, 2022 (Filed With SEC on June 5, 2023)

Class F Common Stock Purchase Warrant issued by Marizyme, Inc. to Walleye Opportunities Master Fund Ltd, dated May 30, 2022 (Filed With SEC on June 5, 2023)

15% Original Issue Discount Unsecured Subordinated Convertible Promissory Note issued by Marizyme, Inc. to Frank Maresca, dated May 30, 2023 (Filed With SEC on June 5, 2023)

Class E Common Stock Purchase Warrant issued by Marizyme, Inc. to Frank Maresca, dated May 30, 2022 (Filed With SEC on June 5, 2023)

Class F Common Stock Purchase Warrant issued by Marizyme, Inc. to Frank Maresca, dated May 30, 2022 (Filed With SEC on June 5, 2023)

Unit Purchase Agreement between Marizyme, Inc. and each investor identified on Appendix A thereto, dated as of May 30, 2022 (Filed With SEC on June 5, 2023)

Registration Rights Agreement between Marizyme, Inc. and each of the several purchasers signatory thereto, dated as of May 30, 2022 (Filed With SEC on June 5, 2023)

Cancellation and Exchange Agreement between Marizyme, Inc. and Hexin Global Ltd., dated as of May 30, 2023 (Filed With SEC on June 5, 2023)

Cancellation and Exchange Agreement between Marizyme, Inc. and Walleye Opportunities Master Fund Ltd, dated as of May 30, 2023 (Filed With SEC on June 5, 2023)

Cancellation and Exchange Agreement between Marizyme, Inc. and Frank Maresca, dated as of May 30, 2023 (Filed With SEC on June 5, 2023)

Class E Common Stock Purchase Warrant issued by Marizyme, Inc., dated May 22, 2022 (Filed With SEC on May 24, 2023)

Class F Common Stock Purchase Warrant issued by Marizyme, Inc., dated May 22, 2022 (Filed With SEC on May 24, 2023)

15% Original Issue Discount Unsecured Subordinated Convertible Promissory Note issued by Marizyme, Inc., dated May 12, 2023 (Filed With SEC on May 18, 2023)

Class E Common Stock Purchase Warrant issued by Marizyme, Inc., dated May 12, 2022 (Filed With SEC on May 18, 2023)

Class F Common Stock Purchase Warrant issued by Marizyme, Inc., dated May 12, 2022 (Filed With SEC on May 18, 2023)

Form of Placement Agent Warrant relating to 15% Original Issue Discount Unsecured Subordinated Convertible Promissory Note (Filed With SEC on May 18, 2023)

Form of Placement Agent Warrant relating to Class E Common Stock Purchase Warrant (Filed With SEC on May 18, 2023)

Form of Placement Agent Warrant relating to Class F Common Stock Purchase Warrant (Filed With SEC on May 18, 2023)

Unit Purchase Agreement between Marizyme, Inc. and each investor identified on Appendix A thereto (Filed With SEC on May 18, 2023)

Registration Rights Agreement between Marizyme, Inc. and each of the several purchasers signatory thereto (Filed With SEC on May 18, 2023)

Placement Agency Agreement between Marizyme, Inc. and Univest Securities, LLC, dated April 27, 2023 (Filed With SEC on May 18, 2023)

Form of Letter Agreement with certain holders of Common Share Purchase Warrants of Marizyme, Inc. dated August 4, 2020 (Filed With SEC on April 20, 2023)

Description of Securities of Marizyme, Inc (Filed With SEC on March 24, 2023)

Form of Underwriting Agreement (Filed With SEC on February 9, 2023)

Unsecured Subordinated Convertible Promissory Note issued by Marizyme, Inc., dated February 6, 2023 (Filed With SEC on February 7, 2023)

Class D Common Stock Purchase Warrant issued by Marizyme, Inc (Filed With SEC on February 7, 2023)

Securities Purchase Agreement, dated as of February 6, 2023, by and between Marizyme, Inc. and Walleye Opportunities Master Fund Ltd (Filed With SEC on February 7, 2023)

Promissory Note issued by Marizyme, Inc. to Hexin Global Ltd., dated December 28, 2022 (Filed With SEC on February 1, 2023)

Form of Unit Warrant (Filed With SEC on February 1, 2023)

Form of Warrant Agent Agreement (Filed With SEC on February 1, 2023)

Waiver and Consent between Marizyme, Inc. and Viner Total Investments Fund, dated January 9, 2023 (Filed With SEC on January 17, 2023)

Letter Agreement between Marizyme, Inc. and Univest Securities, LLC, dated January 12, 2023 (Filed With SEC on January 17, 2023)

Form of Underwriting Agreement (Filed With SEC on November 2, 2022)

Common Stock Purchase Warrant issued to AAT Services Inc., dated December 21, 2021 (Filed With SEC on November 2, 2022)

Common Stock Purchase Warrant issued to Rydra Capital Corp., dated December 21, 2021 (Filed With SEC on November 2, 2022)

Form of Warrant (Filed With SEC on November 2, 2022)

Marizyme, Inc. Amended and Restated 2021 Stock Incentive Plan (Filed With SEC on November 2, 2022)

Form of Stock Option Agreement for Marizyme, Inc. Amended and Restated 2021 Stock Incentive Plan (Filed With SEC on November 2, 2022)

Form of Restricted Stock Award Agreement for Marizyme, Inc. Amended and Restated 2021 Stock Incentive Plan (Filed With SEC on November 2, 2022)

Form of Restricted Stock Unit Award Agreement for Marizyme, Inc. Amended and Restated 2021 Stock Incentive Plan (Filed With SEC on November 2, 2022)

Agreement to Transfer Option and Amendatory Agreement, among Marizyme, Inc., James Sapirstein and Bevilacqua PLLC as escrow agent, dated March 3, 2022 (Filed With SEC on November 2, 2022)

Form of Indemnification Agreement between Marizyme, Inc. and each current officer or director (Filed With SEC on November 2, 2022)

Form of Independent Director Agreement between Marizyme, Inc. and each current non-executive director (Filed With SEC on November 2, 2022)

Waiver, dated July 22, 2022, between Marizyme, Inc. and Viner Total Investments Fund (Filed With SEC on November 2, 2022)

Waiver, dated July 22, 2022, between Marizyme, Inc. and Waichun Logistics Technology Limited (Filed With SEC on November 2, 2022)

Form of Limited Waiver and Consent between Marizyme, Inc. and certain investors (Filed With SEC on November 2, 2022)

10% Secured Convertible Promissory Note issued by Marizyme, Inc., dated August 12, 2022 (Filed With SEC on August 18, 2022)

Class C Common Stock Purchase Warrant issued by Marizyme, Inc., dated August 12, 2022 (Filed With SEC on August 18, 2022)

Form of 10% Secured Convertible Promissory Note issued by Marizyme, Inc., dated June 17, 2022 (Filed With SEC on August 15, 2022)

Form of Class C Common Stock Purchase Warrant issued by Marizyme, Inc., dated June 17, 2022 (Filed With SEC on August 15, 2022)

Form of Placement Agent Warrants issued on June 26, 2022 (Filed With SEC on August 15, 2022)

First Amendment to Lease, dated March 16, 2022, between JIC Equities, LLC and Marizyme, Inc., dated (Filed With SEC on August 15, 2022)

Common Stock Purchase Warrant issued to Bradley Richmond, dated January 26, 2022 (Filed With SEC on May 16, 2022)

Common Stock Purchase Warrant issued to Bradley Richmond, dated February 14, 2022 (Filed With SEC on May 16, 2022)

Form of 10% Secured Convertible Promissory Note issued by Marizyme, Inc., dated March 24, 2022 (Filed With SEC on May 16, 2022)

Form of Class C Common Stock Purchase Warrant issued by Marizyme, Inc., dated March 24, 2022 (Filed With SEC on May 16, 2022)

Form of 10% Secured Convertible Promissory Note issued by Marizyme, Inc., dated May 11, 2022 (Filed With SEC on May 16, 2022)

Form of Class C Common Stock Purchase Warrant issued by Marizyme, Inc., dated May 11, 2022 (Filed With SEC on May 16, 2022)

Agreement to Transfer Option and Amendatory Agreement, among Marizyme, Inc., James Sapirstein and Bevilacqua PLLC as escrow agent, dated March 3, 2022 (Filed With SEC on May 16, 2022)

Description of Securities of Marizyme, Inc (Filed With SEC on March 31, 2022)

Common Stock Purchase Warrant issued to Bradley Richmond, dated January 26, 2022 (Filed With SEC on March 31, 2022)

Common Stock Purchase Warrant issued to Bradley Richmond, dated February 14, 2022 (Filed With SEC on March 31, 2022)

Incentive Stock Option Agreement with George Kovalyov, dated March 17, 2022 (Filed With SEC on March 31, 2022)

Incentive Stock Option Agreement with Harrison Ross, dated March 17, 2022 (Filed With SEC on March 31, 2022)

Incentive Stock Option Agreement with Bradley Richmond, dated March 17, 2022 (Filed With SEC on March 31, 2022)

Indemnification Agreement dated November 1, 2020 with James Sapirstein (Filed With SEC on March 31, 2022)

Indemnification Agreement dated November 1, 2020 with Bruce Harmon (Filed With SEC on March 31, 2022)

Services Agreement dated March 1, 2021 between Marizyme, Inc. and James Sapirstein (Filed With SEC on March 31, 2022)

Director Agreement, dated as of December 6, 2018, between Marizyme, Inc. and James Sapirstein (Filed With SEC on March 31, 2022)

Agreement to Transfer Option and Amendatory Agreement, dated March 3, 2022, between Marizyme, Inc., James Sapirstein and Bevilacqua PLLC, as escrow agent (Filed With SEC on March 31, 2022)

Stock Option Agreement with James Sapirstein dated June 12, 2019 (Filed With SEC on February 14, 2022)

Stock Option Agreement with Terry Brostowin dated December 6, 2018 (Filed With SEC on February 14, 2022)

Stock Option Agreement with Frank Maresca dated July 13, 2019 (Filed With SEC on February 14, 2022)

Stock Option Agreement with Frank Maresca dated January 9, 2020 (Filed With SEC on February 14, 2022)

Stock Option Agreement with James Sapirstein dated July 13, 2019 (Filed With SEC on February 14, 2022)

Stock Option Agreement with Terry Brostowin dated July 13, 2019 (Filed With SEC on February 14, 2022)

Common Stock Purchase Warrant issued to Bradley Richmond, dated October 2, 2020 (Filed With SEC on February 14, 2022)

Common Stock Purchase Warrant issued to Bradley Richmond, dated January 24, 2022 (Filed With SEC on February 14, 2022)

Common Stock Purchase Warrant issued to Univest Securities, LLC, dated January 24, 2022 (Filed With SEC on February 14, 2022)

Mutual Release of Claims Agreement by and between Marizyme, Inc. and Nicholas DeVito dated August 27, 2020 (Filed With SEC on February 14, 2022)

Form of Guarantors Security Agreement, dated as of May 20, 2021, between Marizyme Sciences, Inc., Somaceutica, Inc., and Somahlution, Inc., and the secured parties signatory... (Filed With SEC on February 14, 2022)

Form of Guaranty, dated as of May 19, 2021, of Marizyme Sciences, Inc., Somaceutica, Inc., and Somahlution, Inc (Filed With SEC on February 14, 2022)

Form of Security Agreement, dated as of May 25, 2021, between Marizyme, Inc. and the secured parties signatory thereto (Filed With SEC on February 14, 2022)

Form of Trademark Security Agreement, dated as of May 19, 2021, between Marizyme, Inc. and the secured parties signatory thereto (Filed With SEC on February 14, 2022)

Form of Patent Security Agreement, dated as of May 19, 2021, between Marizyme, Inc. and the secured parties signatory thereto (Filed With SEC on February 14, 2022)

Consulting Agreement, dated September 30, 2020, by and between Marizyme, Inc. and Bradley Richmond (Filed With SEC on February 14, 2022)

Consulting Agreement, dated December 21, 2021, by and among Marizyme, Inc., Rydra Capital Corp., and Harrison Ross (Filed With SEC on February 14, 2022)

Letter Agreement, dated March 5, 2021, between Marizyme, Inc. and Bruce Harmon (Filed With SEC on February 14, 2022)

Lease, dated December 11, 2020, between JIC Equities, LLC and Marizyme, Inc (Filed With SEC on February 14, 2022)

Executive Employment Agreement, dated July 26, 2021, between Marizyme, Inc. and Catherine Pachuk (Filed With SEC on February 14, 2022)

Marizyme Employment Terms and Conditions Agreement, dated January 18, 2021, between Marizyme, Inc. and Amy Chandler (Filed With SEC on February 14, 2022)

Stock Option Agreement, dated January 29, 2021, between Marizyme, Inc. and Amy Chandler (Filed With SEC on February 14, 2022)

Marizyme Employment Terms and Conditions Agreement, dated February 25, 2021, between Marizyme, Inc. and Roger Schaller (Filed With SEC on February 14, 2022)

Employment Offer Letter, dated January 16, 2021, between Marizyme, Inc. and Roger Schaller (Filed With SEC on February 14, 2022)

Stock Option Agreement, dated January 16, 2021, between Marizyme, Inc. and Roger Schaller (Filed With SEC on February 14, 2022)

Confidential Separation Agreement and General Release, dated September 14, 2021, between Marizyme, Inc. and Roger Schaller (Filed With SEC on February 14, 2022)

Amendment to Executive Employment Agreement, dated as of February 8, 2022, between Marizyme, Inc. and David Barthel (Filed With SEC on February 9, 2022)

Form of Unit Purchase Agreement between Marizyme, Inc. and the investors signatory thereto (Filed With SEC on December 27, 2021)

Form of Registration Rights Agreement between Marizyme, Inc. and the investors signatory thereto (Filed With SEC on December 27, 2021)

Form of 10% Secured Convertible Promissory Note issued by Marizyme, Inc (Filed With SEC on December 27, 2021)

Form of Class C Common Stock Purchase Warrant issued by Marizyme, Inc (Filed With SEC on December 27, 2021)

Form of Exchange Agreement between Marizyme, Inc. and the person executing the signature page thereto (Filed With SEC on December 27, 2021)

Placement Agency Agreement between Marizyme, Inc. and Univest Securities, LLC, dated December 10, 2021 (Filed With SEC on December 27, 2021)

Consulting Agreement, dated December 21, 2021, by and among Marizyme, Inc., AAT Services Inc., and George Kovalyov (Filed With SEC on December 27, 2021)

Executive Employment Agreement (Filed With SEC on November 16, 2021)

Form of Unit Purchase Agreement, dated May 2021 (Filed With SEC on August 23, 2021)

Form of 10% Secured Convertible Promissory Note Agreement (Filed With SEC on August 23, 2021)

Form of Class A Common Stock Purchase Warrant (Filed With SEC on August 23, 2021)

Form of Class B Common Stock Purchase Warrant (Filed With SEC on August 23, 2021)

Form of Placement Agency Agreement (Filed With SEC on August 23, 2021)

Form of Placement Agent Warrant Agreement (Filed With SEC on August 23, 2021)

Indemnification Agreement dated November 1, 2020 with James Sapirstein (Filed With SEC on April 15, 2021)

Indemnification Agreement dated November 1, 2020 with Terry Brostowin (Filed With SEC on April 15, 2021)

Indemnification Agreement dated November 1, 2020 with Bruce Harmon (Filed With SEC on April 15, 2021)

Marizyme, Inc. 2021 Stock Incentive Plan (Filed With SEC on April 15, 2021)

Services Agreement dated March 1, 2021 between Marizyme, Inc. and James Sapirstein (Filed With SEC on April 15, 2021)

Offer Letter between Marizyme, Inc. and Dr. Steven Brooks dated December 1, 2020 (Filed With SEC on April 15, 2021)

Offer Letter between Marizyme, Inc. and Dr. Donald Very dated December 2, 2020 (Filed With SEC on April 15, 2021)

Offer Letter between Marizyme, Inc. and Roger Schaller dated January 16, 2021 (Filed With SEC on April 15, 2021)

Consulting Agreement between Marizyme, Inc. and Lakeport Business Services, Inc. (Bruce Harmon) dated August 27, 2020 (Filed With SEC on April 15, 2021)

INDEMNIFICATION AGREEMENT (Filed With SEC on November 16, 2020)

PLACEMENT AGENT WARRANT MARIZYME, INC. (Filed With SEC on August 14, 2020)

SUBSCRIPTION AGREEMENT To subscribe for shares of Common Stock in the private offering of MARIZYME, INC. (Filed With SEC on August 14, 2020)

AMENDMENT NO. 3 TO ASSET PURCHASE AGREEMENT DATED DECEMBER 15, 2019 (Filed With SEC on August 5, 2020)

AMENDMENT 1 to the ASSET PURCHASE AGREEMENT Dated December 15, 2019 (Filed With SEC on June 5, 2020)

AMENDMENT 2 to the ASSET PURCHASE AGREEMENT Dated May 29, 2020 (Filed With SEC on June 5, 2020)

LICENSING and DISTRIBUTION AGREEMENT (Filed With SEC on June 5, 2020)

EMPLOYMENT AGREEMENT (Filed With SEC on February 25, 2020)

ASSET PURCHASE AGREEMENT (Filed With SEC on December 19, 2019)

MARIZYME, INC. INCENTIVE STOCK OPTION AGREEMENT 2019 E QUITY INCENTIVE PLAN (Filed With SEC on November 13, 2019)

LICENSING and DISTRIBUTION AGREEMENT (Filed With SEC on November 13, 2019)

MARIZYME, INC. SUBSCRIPTION AGREEMENT (Filed With SEC on July 3, 2019)

MARIZYME, INC. COMMON SHARE PURCHASE WARRANT (Filed With SEC on July 3, 2019)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 5, 2019)

DIRECTOR AGREEMENT (Filed With SEC on March 5, 2019)

STOCK PURCHASE AGREEMENT (Filed With SEC on June 13, 2013)

SECURED PROMISSORY NOTE (Filed With SEC on May 2, 2013)

COMMONSTOCK PURCHASE WARRANT (Filed With SEC on May 2, 2013)

COMMON STOCKPURCHASE WARRANT (Filed With SEC on May 2, 2013)

SECURED PROMISSORY NOTE (Filed With SEC on May 2, 2013)

COMMON STOCKPURCHASE WARRANT (Filed With SEC on May 2, 2013)

COMMON STOCK PURCHASEWARRANT (Filed With SEC on May 2, 2013)

STOCK PURCHASE AGREEMENT (Filed With SEC on February 7, 2013)

NOTE PURCHASEAND SECURITY AGREEMENT (Filed With SEC on December 7, 2012)

GBS ENTERPRISESINCORPORATED SECUREDPROMISSORY NOTE NOVEMBER30, 2012 (Filed With SEC on December 7, 2012)

COMMON STOCKPURCHASE WARRANT (Filed With SEC on December 7, 2012)

NOTE PURCHASEAND SECURITY AGREEMENT (Filed With SEC on December 7, 2012)

GBS ENTERPRISESINCORPORATED SECUREDPROMISSORY NOTE November30, 2012 (Filed With SEC on December 7, 2012)

COMMON STOCKPURCHASE WARRANT (Filed With SEC on December 7, 2012)

NOTE PURCHASEAGREEMENT (Filed With SEC on November 20, 2012)

GROUP BusinesssoFTWARE ag PROMISSORYNOTE November14, 2012 (Filed With SEC on November 20, 2012)

NOTE PURCHASEAND SECURITY AGREEMENT (Filed With SEC on November 2, 2012)

GBS ENTERPRISESINCORPORATED SECUREDPROMISSORY NOTE OCTOBER26, 2012 (Filed With SEC on November 2, 2012)

COMMON STOCKPURCHASE WARRANT (Filed With SEC on November 2, 2012)

NOTE PURCHASEAGREEMENT (Filed With SEC on November 2, 2012)

GROUP BusinesssoFTWARE ag PROMISSORYNOTE OCTOBER29, 2012 (Filed With SEC on November 2, 2012)

NOTE PURCHASE AND SECURITY AGREEMENT (Filed With SEC on August 16, 2012)

GBS ENTERPRISES INCORPORATED (a Nevada corporation) 2011 STOCK OPTION PLAN (the “Plan”) (Filed With SEC on July 19, 2012)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on April 16, 2012)

securitiespurchase agreement (Filed With SEC on April 16, 2012)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on April 9, 2012)

ACQUISITION AGREEMENT AMENDMENT (Filed With SEC on April 9, 2012)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on March 30, 2012)

[Remainder of the Page IntentionallyBlank] (Filed With SEC on March 6, 2012)

[Remainder of the Page Intentionally Blank] (Filed With SEC on March 6, 2012)

CONSULTANT SERVICESAGREEMENT (Filed With SEC on February 28, 2012)

ACQUISITION AGREEMENT (Filed With SEC on October 4, 2011)

ACQUISITION AGREEMENT (Filed With SEC on July 28, 2011)

ACQUISITION AGREEMENT (Filed With SEC on June 27, 2011)

Asset Purchase Agreement, dated April 26, 2010, between SWAV Enterprises Ltd. and Lotus Holdings Limited (Filed With SEC on April 26, 2010)

Non-Affiliate Stock Purchase Agreement, dated April 26, 2010, between the Selling Stockholders and Joerg Ott (Filed With SEC on April 26, 2010)

Affiliate Stock Purchase Agreement, dated April 26, 2010, between the Selling Stockholders and Joerg Ott (Filed With SEC on April 26, 2010)

Subsidiary Stock Purchase Agreement, dated April 26, 2010, between SWAV Enterprises Ltd. and Pui Shan Lam (Filed With SEC on April 26, 2010)

Stock Purchase Agreement, dated September 21, 2009, between the Selling Stockholders and Sandy J. Masselli (Filed With SEC on September 21, 2009)

Share Transaction Purchase Agreement, dated September 21, 2009, between SWAV Enterprises, Ltd. and Carlyle Gaming Limited (Filed With SEC on September 21, 2009)

Subsidiary Stock Purchase Agreement, dated September 21, 2009, between SWAV Enterprises, Ltd. and Pui Shan Lam (Filed With SEC on September 21, 2009)

Category

Industry

Companies

Contracts

MARIZYME INC Contracts & Agreements